Inhibition of glutaminolysis; antiproliferation and antiremodeling; prevention of PAH progression and reversal of an already established diseased condition; suppression of mTOR signaling, thereby attenuating mTOR-mediated fibrosis. The gene discussed is MTOR; the disease is pulmonary arterial hypertension.